Intravitreal injection of triamcinolone acetonide for the treatment of macular edema;Traitement des œdèmes maculaires par injection intravitréenne d'acétonide de triamcinolone

Journal Francais d'Ophtalmologie

Volumn 28, Issue 7, 2005, Pages 749-757

  Ladjimi, A ^a   Zeghidi, H ^a   Ben Yahia, S ^a   Zaouali, S ^a   Jenzri, S ^b   Messaoud, R ^b   Attia, S ^a   Khairallah, M ^a  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^b CHU Tahar Sfar   (Tunisia)

Author keywords

Intravitreal triamcinolone; Macular edema

Indexed keywords

TRIAMCINOLONE; GLUCOCORTICOID; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; AGED; ANESTHESIA; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EXUDATIVE RETINITIS; EYE INFLAMMATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INJECTION; INTRAOCULAR HYPERTENSION; MALE; POSTOPERATIVE COMPLICATION; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; RETINA VEIN OCCLUSION; SCHOOL CHILD; VISUAL ACUITY; CHILD; MIDDLE AGED; RETINA MACULA CYSTOID EDEMA; VITREOUS BODY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 26944459212     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0181-5512(05)80988-X     Document Type: Article

References (24)

1. Graham RO, Peyman GA. Intravitreal injection of dexamethasone. Arch Ophthalmol, 1974;92:149-54.
2. McCuen BW, Bessler M, Tano Y, Chandler D, Machemer R. The lack of toxicity of intravitreal administered triamcinolone acetonide. Am J Ophthalmol, 1981;91:785-8.
3. Jonas JB, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol, 2001;132:425-7.
4. Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol, 2002;120:1217-9
5. Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol, 2003;135:246-9.
6. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Fytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology, 2001;108:765-72.
7. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina, 2000;20:244-50.
8. Jonas JB, Hayler JK, Sofker A, Panda-Jonas S, Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone. J Glaucoma, 2001;10:284-7.
9. Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol, 2000;84:1064-7.
10. Jonas JB. Concentration of intravitreally injected triamcinolone acetonide in aqueous humour. Br J Ophthalmol, 2002;86:1066.
11. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters III GB, Miller M. Intraocular concentration and pharmakokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology, 2003;110:681-6.
12. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol, 2003;121:57-61.
13. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology, 2002;109:920-7.
14. Gastaud P, Schauer P, Rouhette H, Folquet P, Negre F. Indications de la chirurgie des maculopathies diabétiques. J Fr Ophtalmol, 2002;25:166-77.
15. Danis RP, Bingaman DP, Yang Y, Ladd B. Inhibition of preretinal and optic nerve head neovascularisation in pigs by intravitreal triamcinolone acetonide. Ophthalmology, 1996;103:2099-104.
16. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol, 2003;136:384-6.
17. Greenberg PB, Martidis A, Roigers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular edema due to central retinal vein occlusion. Br J Ophthalmol, 2002;86:247-8.
18. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol, 2002;240:782-3.
19. Park, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol, 2003;136:419-25.
20. Young S, Larkin G, Branley M, Lightman S. Safety end efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol, 2001;29:2-6.
21. Sutter FKP, Gillies MC. Pseudo-endophtalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol, 2003;87:972-4.
22. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudry NA. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol, 2003;121:1279-82.
23. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol, 2003;87:24-7.
24. Jonas JB, Kreissig I, Degenring R. Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide, Arch Ophthalmol, 2003;121:729-30,